Penumbra, Inc Restructuring and Related Cost, Incurred Cost
Penumbra, Inc (PEN) reported Restructuring and Related Cost, Incurred Cost of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2026-02-25
- Penumbra, Inc restructuring and related cost, incurred cost for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Penumbra, Inc restructuring and related cost, incurred cost for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Penumbra, Inc restructuring and related cost, incurred cost for the quarter ending 2024-12-31 was $110.28M.
- Penumbra, Inc restructuring and related cost, incurred cost for the quarter ending 2024-09-30 was $5.00M.
- Penumbra, Inc restructuring and related cost, incurred cost for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Penumbra, Inc restructuring and related cost, incurred cost for fiscal 2024 was $115.28M.
| Period end | Restructuring and Related Cost, Incurred Cost 3 month | Restructuring and Related Cost, Incurred Cost 3 month as first filed | Restructuring and Related Cost, Incurred Cost 6 month | Restructuring and Related Cost, Incurred Cost 9 month | Restructuring and Related Cost, Incurred Cost 9 month as first filed | Restructuring and Related Cost, Incurred Cost 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||||
| 2024-12-31 | $110.28M derived: 10-K 12 month − 10-K 9 month · filed 2025-02-18 | $115.28M derived: sum of 2 quarters · filed 2026-02-25 | $115.28M 10-K · filed 2025-02-18 | |||
| 2024-09-30 | $5.00M 10-K · filed 2026-02-25 | $4.97M 10-Q · filed 2024-10-30 | $5.00M 10-K · filed 2026-02-25 | $4.97M 10-Q · filed 2024-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |